OPKO Health Cost of Goods Sold 2010-2024 | OPK

OPKO Health cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
OPKO Health Annual Cost of Goods Sold
(Millions of US $)
2024 $495
2023 $545
2022 $716
2021 $1,193
2020 $894
2019 $572
2018 $605
2017 $620
2016 $611
2015 $235
2014 $48
2013 $49
2012 $28
2011 $17
2010 $13
2009 $3
OPKO Health Quarterly Cost of Goods Sold
(Millions of US $)
2024-12-31 $99
2024-09-30 $134
2024-06-30 $131
2024-03-31 $132
2023-12-31 $137
2023-09-30 $131
2023-06-30 $139
2023-03-31 $138
2022-12-31 $129
2022-09-30 $148
2022-06-30 $194
2022-03-31 $244
2021-12-31 $293
2021-09-30 $244
2021-06-30 $293
2021-03-31 $364
2020-12-31 $319
2020-09-30 $273
2020-06-30 $163
2020-03-31 $140
2019-12-31 $142
2019-09-30 $142
2019-06-30 $144
2019-03-31 $144
2018-12-31 $150
2018-09-30 $151
2018-06-30 $150
2018-03-31 $154
2017-12-31 $157
2017-09-30 $151
2017-06-30 $157
2017-03-31 $155
2016-12-31 $159
2016-09-30 $151
2016-06-30 $153
2016-03-31 $148
2015-12-31 $143
2015-09-30 $67
2015-06-30 $14
2015-03-31 $10
2014-12-31 $12
2014-09-30 $11
2014-06-30 $13
2014-03-31 $12
2013-12-31 $12
2013-09-30 $12
2013-06-30 $13
2013-03-31 $12
2012-12-31 $9
2012-09-30 $7
2012-06-30 $7
2012-03-31 $5
2011-12-31 $4
2011-09-30 $4
2011-06-30 $5
2011-03-31 $4
2010-12-31 $-0
2010-09-30 $3
2010-06-30 $5
2010-03-31 $6
2009-12-31 $-2
2009-09-30 $1
2009-06-30 $2
2009-03-31 $2
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.115B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $187.725B 22.76
Intuitive Surgical (ISRG) United States $176.405B 80.93
Alcon (ALC) Switzerland $46.824B 31.12
Edwards Lifesciences (EW) United States $42.608B 27.66
IDEXX Laboratories (IDXX) United States $34.032B 39.36
IQVIA Holdings (IQV) United States $31.084B 17.20
DexCom (DXCM) United States $26.777B 41.39
Mettler-Toledo (MTD) United States $24.611B 28.69
STERIS (STE) Ireland $22.269B 25.47
Waters (WAT) United States $21.897B 31.05
SONOVA HOLDING (SONVY) Switzerland $17.380B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $14.612B 14.91
Hologic (HOLX) United States $13.861B 14.96
Sysmex ADR (SSMXY) Japan $11.941B 37.44
Penumbra (PEN) United States $10.300B 93.17
Globus Medical (GMED) United States $10.068B 23.31
Masimo (MASI) United States $9.002B 37.78
Teleflex (TFX) United States $6.407B 9.86
Glaukos (GKOS) United States $5.567B 0.00
Integer Holdings (ITGR) United States $3.967B 22.27
PROCEPT BioRobotics (PRCT) United States $3.194B 0.00
Veracyte (VCYT) United States $2.311B 41.76
TransMedics (TMDX) United States $2.265B 66.61
Nihon Kohden (NHNKY) Japan $2.205B 12.06
LivaNova (LIVN) United Kingdom $2.135B 12.96
Elekta AB (EKTAY) Sweden $1.995B 17.93
Integra LifeSciences Holdings (IART) United States $1.698B 8.59
Alphatec Holdings (ATEC) United States $1.462B 0.00
Tandem Diabetes Care (TNDM) United States $1.274B 0.00
Paragon 28 (FNA) United States $1.096B 0.00
Artivion (AORT) United States $1.034B 98.32
RxSight (RXST) United States $1.022B 0.00
Pulse Biosciences (PLSE) United States $0.990B 0.00
AxoGen (AXGN) United States $0.820B 0.00
IRadimed (IRMD) United States $0.667B 34.99
AVANOS MEDICAL, INC (AVNS) United States $0.659B 10.61
Mesa Laboratories (MLAB) United States $0.645B 14.09
ORTHOFIX MEDICAL INC (OFIX) United States $0.636B 0.00
OrthoPediatrics (KIDS) United States $0.598B 0.00
SiBone (SIBN) United States $0.596B 0.00
Beta Bionics (BBNX) United States $0.531B 0.00
Treace Medical Concepts (TMCI) United States $0.525B 0.00
Delcath Systems (DCTH) United States $0.425B 0.00
NeuroPace (NPCE) United States $0.400B 0.00
AngioDynamics (ANGO) United States $0.380B 0.00
Pacific Biosciences Of California (PACB) United States $0.351B 0.00
Semler Scientific (SMLR) United States $0.347B 7.37
ClearPoint Neuro (CLPT) United States $0.329B 0.00
CVRx (CVRX) United States $0.318B 0.00
Tactile Systems Technology (TCMD) United States $0.313B 16.73
Nevro (NVRO) United States $0.224B 0.00
Inogen (INGN) United States $0.192B 0.00
Accuray (ARAY) United States $0.184B 0.00
Alpha Tau Medical (DRTS) Israel $0.177B 0.00
LENSAR (LNSR) United States $0.166B 0.00
908 Devices (MASS) United States $0.158B 0.00
Spectral Diagnostics (EDTXF) Canada $0.147B 0.00
Lucid Diagnostics (LUCD) United States $0.135B 0.00
Anteris Technologies Global (AVR) Australia $0.131B 0.00
Sight Sciences (SGHT) United States $0.123B 0.00
KORU Medical Systems (KRMD) United States $0.117B 0.00
Rapid Micro Biosystems (RPID) United States $0.114B 0.00
Neuronetics (STIM) United States $0.112B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Atossa Genetics (ATOS) United States $0.087B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
Sensus Healthcare (SRTS) United States $0.078B 11.82
EDAP TMS S.A (EDAP) France $0.073B 0.00
Zomedica (ZOMDF) United States $0.057B 0.00
Hyperfine (HYPR) United States $0.056B 0.00
Microbot Medical (MBOT) United States $0.052B 0.00
EnVVeno Medical (NVNO) United States $0.046B 0.00
Vicarious Surgical (RBOT) United States $0.039B 0.00
Baird Medical Investment Holdings (BDMD) $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.027B 0.00
Envoy Medical (COCH) United States $0.026B 0.00
DarioHealth (DRIO) United States $0.025B 0.00
NexGel (NXGL) United States $0.023B 0.00
Accelerate Diagnostics (AXDX) United States $0.018B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Biosig Technologies (BSGM) United States $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.008B 0.00
WORK Medical Technology Group (WOK) China $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Aspira Women's Health (AWH) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00